Handoko K B, van Asselt G J, Overdiek J W
Afd. Ziekenhuisapotheek, Medisch Centrum Haaglanden, Den Haag.
Ned Tijdschr Geneeskd. 2004 Jan 31;148(5):222-6.
To reduce the number of days of unnecessary intravenous antibiotic therapy via an early switch to oral antibiotic therapy.
Prospective, open trial.
A guideline was drawn up for an early and yet safe switch from intravenous to oral antibiotic therapy. Patients on the wards of Internal Medicine, Pulmonology, Surgery and Orthopaedics of the Haaglanden Medical Centre in The Hague, the Netherlands, were followed for four months. A zero measurement at two months was followed by an intervention period of two months. The number of unnecessary days of intravenous antibiotic therapy was taken as the measure of effectiveness. A multidisciplinary team carried out the interventions, consisting of educational, supportive and guiding measures. Making progress measurable and giving feedback played an important role during the intervention.
During the zero-measurement period on the Internal Medicine and Pulmonology wards, 26% (9/35) of patients were switched within the timeframe predefined by the guideline. The average number of unnecessary i.v. days was 2.4 (median: 2). During the intervention period, 84% (64/76) were switched within the predefined timeframe, with an average of 0.2 unnecessary i.v. days per patient (median: 0). There was thus a significantly lower number of unnecessary i.v. days after intervention (difference: 2.2; 95%-CI: 1.5-3.0). On the surgical and orthopaedic wards, 9% (2/22) of patients were switched within the predefined timeframe during the zero-measurement period, with an average of 7.3 unnecessary i.v. days (median: 5). During the intervention period, 52% of patients (17/33) were switched within the predefined timeframe, for an average of 1.1 unnecessary i.v. days (median: 0). The reduction in the number of unnecessary i.v. days was also significant here (difference: 6.2; 95%-CI: 2.9-9.5).
A significant reduction in the number of unnecessary days of intravenous antibiotic therapy was obtained via simple interventions carried out by a multidisciplinary team.
通过尽早改用口服抗生素治疗,减少不必要的静脉抗生素治疗天数。
前瞻性开放试验。
制定了一项关于从静脉抗生素治疗尽早且安全地转换为口服抗生素治疗的指南。对荷兰海牙哈格兰登医疗中心内科、肺病科、外科和骨科病房的患者进行了四个月的跟踪。在两个月时进行零测量,随后是两个月的干预期。将不必要的静脉抗生素治疗天数作为有效性的衡量标准。一个多学科团队实施了干预措施,包括教育、支持和指导措施。在干预过程中,使进展可衡量并给予反馈起到了重要作用。
在内科和肺病科病房的零测量期,26%(9/35)的患者在指南预先定义的时间范围内完成了转换。不必要的静脉治疗天数平均为2.4天(中位数:2天)。在干预期,84%(64/76)的患者在预先定义的时间范围内完成了转换,每位患者平均有0.2天不必要的静脉治疗(中位数:0天)。因此,干预后不必要的静脉治疗天数显著减少(差异:2.2;95%置信区间:1.5 - 3.0)。在外科和骨科病房,零测量期有9%(2/22)的患者在预先定义的时间范围内完成了转换,平均有7.3天不必要的静脉治疗(中位数:5天)。在干预期,52%的患者(17/33)在预先定义的时间范围内完成了转换,平均有1.1天不必要的静脉治疗(中位数:0天)。此处不必要的静脉治疗天数减少也很显著(差异:6.2;95%置信区间:2.9 - 9.5)。
通过多学科团队实施的简单干预措施,不必要的静脉抗生素治疗天数显著减少。